Cantor Fitzgerald Comments on Cytokinetics FY2026 Earnings
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Cytokinetics in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst C. Gould anticipates that the biopharmaceutical company will post earnings of ($3.59) per share for the year. Cantor Fitzgerald currently has […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Cytokinetics in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst C. Gould anticipates that the biopharmaceutical company will post earnings of ($3.59) per share for the year. Cantor Fitzgerald currently has […]
